Learning Objectives

By the end of this comprehensive lecture guide, you will be deeply conversant with:

• Fundamental definitions: What is a drug, and what is pharmacology?
• The subdivisions of pharmacology, focusing heavily on Pharmacokinetics.
• The mechanisms, factors, and clinical importance of drug Absorption and Bioavailability.
• The concept of Drug Distribution across various body fluid compartments.
• How to define, calculate, and interpret the Volume of Distribution (Vd).
• The critical role of Plasma Protein Binding and the dangers of drug displacement.
• Physiological factors affecting distribution (Blood Brain Barrier, tissue binding, pathology).

---

What is a Drug?

In pharmacology, a drug is defined as any chemical agent which affects any biological process. This is a very broad definition intentionally. It does not just mean medicine prescribed by a doctor; it includes naturally occurring substances, synthetic laboratory chemicals, recreational substances, and even everyday items like caffeine or alcohol, provided they cause a change in biological function when introduced to the body.

What is Pharmacology?

Pharmacology is the overarching scientific study of how drugs affect biological systems. To make this massive field manageable, it is divided into several specific sub-disciplines:

---

Introduction to Pharmacokinetics

Pharmacokinetics is the journey of the drug through the body. It dictates how much of a dose actually reaches the target organ and how long it stays there. It is defined by four core processes (remembered by the acronym ADME):

• Absorption: The drug entering the blood.
• Distribution: The drug traveling via the blood to tissues.
• Metabolism (Biotransformation): The body (usually the liver) chemically altering the drug.
• Excretion: The body (usually the kidneys) removing the drug.

Absorption of the Drug

Absorption is the crucial first stage. It is defined as the process that involves the movement (transportation or passage) of a drug from its site or route of administration (e.g., the gut for an oral pill, the muscle for an injection) across biological membranes into the systemic blood stream.

---

Mechanisms Used by Drugs to Cross Membranes

Cell membranes are essentially biological barriers made of a lipid (fat) bilayer. Drugs must navigate this barrier using one of four primary mechanisms:

1. Simple (Passive) Diffusion

This is the most common way drugs are absorbed. "Passive" means it happens naturally without the body spending any energy.

• Mechanism: Drugs move down a concentration gradient (from an area of high concentration, like the stomach, to an area of low concentration, like the blood).
• Energy: No energy (ATP) is required.
• Carriers: There is no use of special transport (carrier) proteins.
• Saturation: Because there are no carriers to get "full," there is no saturation gradient required; as long as there is a concentration difference, diffusion continues.

Types of Passive Diffusion:

• Via Aqueous Pores: Highly water-soluble (ionized or polar) drugs slip through tiny water-filled channels or pores in the membrane. Examples: Caffeine, ascorbic acid (Vitamin C), acetylsalicylic acid (Aspirin), nicotinamide. However, because these pores are very small, they play a limited role overall.
• Via the Lipid Layer: Highly lipid-soluble (non-ionized or non-polar) drugs dissolve directly into and pass through the fat of the cell membrane itself. Examples: Artemisinin, lumefantrine (antimalarials). The lipid layer plays the major role in simple diffusion.

2. Facilitated Diffusion

While still a passive process (no energy used), this mechanism requires a "helper."

• Mechanism: It occurs by the use of carrier proteins located within the cell membrane. The drug binds to the protein, the protein changes shape, and releases the drug on the other side.
• Gradient: The net flux is still from high concentration to low concentration.
• Energy: No energy is required.
• Saturation: Unlike simple diffusion, this requires a saturable gradient. Since there is a limited number of carrier proteins, if there is too much drug, all carriers become busy (saturated), and absorption maxes out.
• Examples: It is used for essential molecules that are too large or too polar for simple diffusion, such as amino acids, glucose, and folic acid.

3. Active Transport

This mechanism forces drugs to move where they naturally wouldn't go.

• Mechanism: Transportation acts against a concentration gradient or an electrochemical gradient (moving from low to high concentration).
• Energy: It strictly requires cellular energy (ATP) to pump the drug across.
• Carriers: It requires special transporter (carrier) proteins.
• Saturation: There is a "transport maximum" (T-max) for the substances; once all pumps are working, rate cannot increase.
• Rate: The rate of active transport heavily depends on the drug concentration in the environment competing for these pumps.

4. Pinocytosis

Also known as "cell drinking," this is reserved for massive molecules.

• Mechanism: Drugs with a Molecular Weight (MW) over 900 are transported this way. The drug molecule adheres to the cell membrane. The membrane then invaginates (folds inward), surrounds the drug, and pinches off to form a small intracellular vesicle.
• Energy: This is a highly active process and requires energy.

---

Factors Affecting Drug Absorption

Drug absorption is not uniform; it varies wildly based on the nature of the drug and the body itself. These factors are split into two categories.

A. Drug-Related Factors

1. Dosage Form: Solid drugs (like tablets) must break down before they can be absorbed.
   • Disintegration: Breaking up of the large tablet into smaller granules/pieces after administration.
   • Dissolution: The solid drug entering into a solvent (stomach fluid) to form a completely dissolved liquid solution.
   • Rule of thumb: Solution forms (liquids, syrups) are absorbed much faster than unsolved (solid) forms because they skip the disintegration and dissolution steps.
2. Chemical Nature: The physical chemistry of the drug matters.
   • Salt Formations: Drugs are often formulated as salts to improve absorption. Salt forms of weak acids (e.g., Sodium, Potassium, Calcium compounds) and weak bases (e.g., HCl, HBr compounds) are much more easily absorbed compared to their original, pure "free" forms.
   • Crystal Forms: An amorphous (unstructured, random) structure of a drug has a higher dissolution rate compared to a tightly packed, rigid crystalline structure.
   • Solvate Form: Drugs can bind to solvent molecules. Hydrates (drugs bound to water molecules) are generally more soluble in water compared to other solvates.
3. Particle Size: Decreasing the particle size (making the powder finer) drastically increases the total surface area exposed to stomach fluids. This fastens its dissolution, thereby increasing the absorption rate.
4. Complex Formation: The solubility of poorly soluble drugs can sometimes be increased by forcing them to form a chemical complex with another, highly soluble molecule.
5. Concentration of the Drug: The higher the concentration of the drug at the administration site, the steeper the concentration gradient, resulting in a higher absorption rate.
6. Molecular Size: There is a negative relationship between molecular size and absorption rate. As molecular size increases, the ability of the drug to cross membranes decreases, lowering the absorption rate.
7. Lipid Solubility: Cell membranes are made of lipids. Therefore, the more lipid-soluble a drug is, the easier it crosses the membrane. This is measured by the lipid-water partition coefficient (K). A high coefficient means high lipid solubility, resulting in excellent absorption.

B. Site of Application Related Factors

• Blood Flow: If the blood flow is high at the site of application (e.g., a well-perfused muscle vs. subcutaneous fat), the absorbed drug is quickly swept away. This maintains a steep concentration gradient, causing a rapid increase in absorption rate.
• Area of Absorption: The wider the surface area, the higher the absorption rate. This is why the small intestine (which has massive surface area due to microvilli) absorbs far more drug than the stomach.

---

Drug Absorption Vs Drug Bioavailability

Absorption is the act of moving into the blood. Bioavailability is a strict measurement of the result.

Definition: Bioavailability is the fraction (or percentage) of the administered dose of a drug that successfully reaches the systemic circulation in an unchanged, active form.

• By definition, the bioavailability of a drug injected directly into the vein (Intravenously / IV) is exactly 100%, because none of the drug is lost; it goes straight into the blood.
• Bioavailability of an oral drug is calculated by plotting a graph of Plasma Concentration over Time, and comparing the Area Under the Curve (AUC) of the oral dose to the AUC of an IV dose.

Bioavailability = (AUC oral / AUC injected) x 100

Measuring Bioavailability Indicators

When looking at a plasma concentration-time graph, two key metrics indicate bioavailability:

• Rate of Absorption (T-max): The time it takes for the drug to reach its maximum peak concentration in the blood. A short T-max means rapid absorption.
• Extent of Absorption (C-max): The maximum concentration (height of the peak) achieved in the blood. This indicates exactly how much of the dose actually entered circulation.

Factors Influencing Bioavailability

Why isn't an oral pill 100% bioavailable? Several hurdles exist:

• First Pass Hepatic Metabolism: When a drug is swallowed, it is absorbed from the gut into the portal vein, which goes straight to the liver before reaching the rest of the body. The liver's job is to destroy toxins. If the liver aggressively metabolizes the drug on this "first pass," very little unchanged drug makes it to systemic circulation, severely dropping bioavailability.
• Solubility of the drug: If it won't dissolve, it won't absorb.
• Chemical instability: Some drugs are destroyed by the harsh stomach acid (e.g., Penicillin G) or digestive enzymes (e.g., Insulin) before they can be absorbed.
• Nature of drug formulation: The excipients, binders, and coatings used by the manufacturer affect dissolution. Bioavailability is vital for comparing two different brands of the same drug to ensure they are Bioequivalent (e.g., ensuring generic brand X acts exactly like name brand Y).

---

Drug Distribution and Fluid Compartments

Once the drug is safely absorbed into the bloodstream, it must travel to its site of action. Drug Distribution is the process by which drugs leave the blood circulation and enter the interstitial fluids (fluid between cells) and/or the intracellular fluids (inside the cells of tissues).

The sequence is: Drug Administration → Absorption → Blood (Plasma) → Extracellular Fluid → Intracellular Fluid.

The Body Fluid Compartments

To understand distribution, we must divide the body's water (which makes up roughly 60% of total body mass, or ~42 Liters in an average adult) into theoretical compartments:

• Extracellular Fluids (22% of body weight): Fluid outside the cells. Comprised of two sub-compartments:
  • Plasma Fluid: The fluid part of the blood. Represents 5% of body weight, or roughly 4 Liters.
  • Interstitial Fluid: The fluid bathing the tissues outside the blood vessels. Represents 16% of body weight, or roughly 10 Liters.
• Intracellular Fluids (35% of body weight): The fluid trapped inside all the billions of cells in the body. Roughly 28 Liters.

---

Volume of Distribution (Vd)

Volume of Distribution (Vd) is a deeply important, yet highly theoretical concept. It answers the question: How much of the drug is distributed into the different body compartments?

It is defined as a hypothetical volume of fluid into which a drug is distributed to produce the concentration observed in the blood plasma. It is the ratio of the drug amount in the entire body (the dose) to the concentration of the drug in the blood.

Vd (Liters) = Dose administered (mg) / Plasma concentration (mg/L)

Why is Vd Important?

Vd is clinically vital for calculating the Loading Dose (a large initial dose given to quickly achieve therapeutic blood levels). Furthermore, a large Vd generally means the drug is hidden deep in the tissues, away from the liver and kidneys, resulting in a long duration of action.

Distribution Scenarios Based on Vd

1. Drugs restricted to the Plasma Compartment Vd ≈ 4 Liters
   • Characteristics: These drugs have a very large molecular weight, or they bind extensively to plasma proteins. They become physically too large to squeeze out through the endothelial slit junctions of the blood capillaries.
   • Result: They are trapped in the blood vascular compartment, meaning they have a low volume of distribution.
   • Examples: Warfarin (binds heavily to proteins), Heparin (massive molecule).
2. Drugs distributed into the Extracellular Compartment Vd ≈ 14 Liters
   • Characteristics: These drugs have a low molecular weight, allowing them to pass through the endothelial capillary slits into the interstitial fluid. However, they are highly hydrophilic (water-soluble/lipid-insoluble).
   • Result: Because they are not lipid-soluble, they cannot cross the lipid cell membrane to enter the cells. They are distributed in Plasma (4L) + Interstitial fluid (10L) = 14 Liters. They still have a relatively low Vd.
   • Examples: Mannitol, Gentamycin, Atracurium, Insulin.
3. Drugs distributed into Total Body Water Vd ≈ 42 Liters
   • Characteristics: These drugs have a low molecular weight and are hydrophobic (lipid-soluble).
   • Result: They easily move out of the capillaries, through the interstitial fluid, and effortlessly cross cell membranes to enter the intracellular fluid. They distribute into the total 42 Liters of body water.
   • Examples: Ethanol (Alcohol) has a Vd equal to total body water (approx 38L, ranging 34-41L).
4. Drugs heavily distributed intracellularly Very High Vd, often > 42L
   • Characteristics: These are highly lipid-soluble drugs that actively bind to tissues outside of the plasma.
   • Result: Because they hide inside tissues, the concentration remaining in the plasma is very low. Mathematically, dividing the dose by a tiny plasma concentration yields a massive Vd. They have higher concentrations in tissues than in plasma.
   • Examples: Digoxin, Phenytoin, Morphine.

---

Plasma Protein Binding

After absorption, a drug circulates in the blood in two forms: Free form or Bound to plasma proteins. This binding is dynamic and reversible.

The plasma constitutes several important binding proteins:

• Albumin: The most abundant protein. Acidic drugs primarily bind to albumin.
• α1-acid glycoprotein: Basic drugs primarily bind here.
• Lipoproteins and others.

The Golden Rules of Protein Binding:

• Bound drugs are kept pharmacologically inactive (only the free fraction can bind to receptors to exert an effect).
• Bound drugs are physical complexes that are too large, so they are prevented from crossing membranes to leave the blood.
• Bound drugs are prevented from being metabolized by the liver.
• Bound drugs are prevented from being excreted by the kidneys.
• Protein-binding capacity is usually much larger than drug concentration, meaning the fraction of drug that remains free is generally constant under normal conditions.

---

Factors Affecting Drug Distribution

Beyond protein binding, several physiological factors dictate where a drug goes:

• Organ Size: Organs with a large physical size (like skeletal muscle) can take up a large overall amount of drug simply driven by the concentration gradient. Conversely, distributing even a small amount of drug into a tiny organ will drastically raise the tissue concentration there.
• Blood Flow: The greater the blood flow (perfusion) to a tissue, the faster the distribution occurs from plasma to interstitium. Drugs distribute very rapidly to highly perfused organs like the brain, liver, and kidneys, much faster than to poorly perfused tissues like resting skeletal muscle and fat.
• Membrane Permeability:
  • Capillary Permeability: In most tissues (like the liver), endothelial cells of capillaries have large fenestrations (wide slit junctions) allowing easy movement and exchange of both lipid and water-soluble drugs.
  • Blood Brain Barrier (BBB): The brain is heavily protected. Brain capillaries lack slits; instead, they have tight junctions and are covered by astrocyte foot processes. Only strictly lipid-soluble drugs or those with active transport carriers can cross the BBB. Hydrophilic (ionized/polar) drugs cannot. Clinical Note: Inflammation, such as in meningitis, damages these tight junctions, increasing permeability and allowing hydrophilic drugs like penicillin and gentamycin to enter the brain to treat the infection.
  • Placental Barrier: Lipid-soluble drugs can easily cross the placental barrier and enter fetal blood, potentially causing harm.
• Tissue Binding: Some drugs have a very specific chemical affinity for macromolecules in certain tissues, accumulating there in high concentrations:
  • Tetracycline binds to calcium in bone and developing teeth.
  • Phenobarbitone accumulates in the brain.
  • Chlorpromazine binds to melanin in the eye.
  • Chloroquine accumulates in the kidneys and liver.
• Other Factors:
  • Fat to Lean Body Mass Ratio: Highly lipid-soluble drugs distribute heavily into fat. Individuals with high body fat percentages will trap more of the drug in fat tissue, slightly decreasing the active concentration available to other organs.
  • Pregnancy: The fetus acts as an additional fluid compartment and tissue mass, increasing the overall distribution volume of the drug.
• Pathological States: Disease alters physiology.
  • Congestive Heart Failure: Alters total body water and reduces blood flow to organs, impairing distribution.
  • Cirrhosis of the Liver: The liver produces albumin. Cirrhosis leads to decreased synthesis of plasma proteins. Less albumin = less protein binding = more dangerous free drug in circulation.
  • Uremia (Kidney Failure): Leads to an accumulation of toxic metabolic waste products in the blood. These wastes compete with drugs for protein binding sites, displacing the drugs and increasing toxicity.

---

Redistribution

For highly lipid-soluble drugs acting on the Central Nervous System (CNS), the termination of their effect is often not due to metabolism or excretion, but due to a phenomenon called Redistribution.

• Mechanism: When an IV dose is given, the drug rushes first to the most highly perfused organs (the brain). The patient falls asleep instantly. However, within minutes, the drug follows the concentration gradient back out of the brain, back into the blood, and redistributes into less-perfused but larger fat tissues. As the drug leaves the brain, the patient wakes up. Therefore, the short duration of action of the initial dose depends almost entirely on the rapid redistribution rate, not the drug's half-life.